Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Julphar
UBS
Teva
QuintilesIMS
Deloitte

Generated: July 22, 2019

DrugPatentWatch Database Preview

Patent: 9,132,138

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,132,138
Title:Method for the treatment of multiple sclerosis
Abstract: A method for treating a subject with multiple sclerosis is disclosed herein. In one embodiment, a method is provided for treating a subject with multiple sclerosis that includes administering to the subject a therapeutically effective amount of 2ME2 or a derivative thereof.
Inventor(s): Mak; Tak Wah (Toronto, CA), Duncan; Gordon Stuart (Toronto, CA)
Assignee: CASI Pharmaceuticals, Inc. (Rockville, MD)
Application Number:13/789,849
Patent Claims:see list of patent claims

Details for Patent 9,132,138

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Biogen ZINBRYTA daclizumab INJECTABLE;INJECTION 761029 001 2016-05-27 ➤ Try a Free Trial CASI Pharmaceuticals, Inc. (Rockville, MD) ➤ Try a Free Trial RX search
Biogen Idec TYSABRI natalizumab VIAL; SINGLE-USE 125104 001 2004-11-23 ➤ Try a Free Trial CASI Pharmaceuticals, Inc. (Rockville, MD) ➤ Try a Free Trial RX search
Genentech RITUXAN rituximab VIAL 103705 001 1997-11-26 ➤ Try a Free Trial CASI Pharmaceuticals, Inc. (Rockville, MD) ➤ Try a Free Trial RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
US Department of Justice
Healthtrust
QuintilesIMS
Fish and Richardson
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.